Pure Bioscience (PURE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 07/31
| 07-2000 | 07-1999 | 07-1998 | 07-1997 | 07-1996 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,320 | 220 | 250 | N/A | N/A |
| Marketable Securities | 0 | 0 | 0 | 1,980 | 20 |
| Receivables | 440 | 790 | 270 | 240 | 180 |
| Inventories | 790 | 710 | 360 | 20 | 50 |
| Other current assets | 240 | 390 | 130 | 590 | 20 |
| TOTAL | $2,790 | $2,110 | $1,010 | $2,830 | $270 |
| Non-Current Assets | |||||
| PPE Net | 1,050 | 800 | 790 | N/A | N/A |
| Other Non-Current Assets | 1,300 | 1,087 | 1,150 | 60 | 7 |
| TOTAL | $2,350 | $1,887 | $1,940 | $60 | $7 |
| Total Assets | $5,160 | $4,010 | $2,970 | $3,630 | $810 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 300 | 590 | 490 | 90 | 230 |
| Accrued Expenses | 30 | 40 | 40 | 60 | 300 |
| TOTAL | $550 | $1,080 | $830 | $150 | $940 |
| Non-Current Liabilities | |||||
| Long Term Debt | 0 | 0 | 0 | 0 | 3 |
| Other Non-Current Liabilities | 62 | 0 | 0 | 0 | 0 |
| TOTAL | $62 | $N/A | $N/A | $N/A | $3 |
| Total Liabilities | $62 | $1,080 | $830 | $150 | $943 |
| Shareholders' Equity | |||||
| Common Shares | 10,010 | 6,660 | 6,230 | 5,560 | 660 |
| Retained earnings | -5,580 | -3,840 | -4,100 | -2,190 | -790 |
| Other shareholders' equity | 110 | 110 | 0 | 100 | 10 |
| TOTAL | $4,540 | $2,930 | $2,130 | $3,470 | $-120 |
| Total Liabilities And Equity | $4,602 | $4,010 | $2,960 | $3,620 | $823 |